The venture arm will focus exclusively on funding early stage companies that have the potential of advancing the science of cannabis. Steep Hill Ventures has a target of making available $100M in equity funding to invest in early stage companies over the next year, providing financing and incubation from Seed through the Series A.
Steep Hill’s financial network will support follow-on investment and commercial capabilities to significantly impact on portfolio companies’ success.
Led by Jmîchaeĺe Keller, President and CEO, Steep Hill is a cannabis science and technology company with expertise in lab testing, research and development, licensing, genetics and remote testing. In 2008, the company opened the first commercial cannabis lab and is currently expanding throughout the United States, and globally.
FinSMEs
16/11/2017